Ben White
JANUARY 26, 2024
RP is offering to exchange its senior secured notes due in 2025 for new first lien notes due in 2029 and its senior unsecured notes due in 2028 for new second lien notes due in 2030. As of the announcement, they were actually still just shy of their target percentage needed to make the math work.)
Imaging Technology
MAY 25, 2023
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030. In the U.S., doi: 10.2967/jnumed.123.265420
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
MARCH 26, 2024
Josephs, MD, FSIR —Secretary Nadine Abi-Jaoudeh, MD, FSIR —Clinical Trials and Registries Division Chair Amy C. Weiss, MD, FSIR —Vice Chair Shellie C.
AuntMinnie
AUGUST 21, 2024
Omary and colleague Thomas Grist, of the University of Wisconsin-Madison in Madison, WI, penned a recent article outlining the concept in the American Journal of Roentgenology , titled “The Translational Medicine of 2030: Bedside to Biosphere.” Why is 2030 the target goal to see the concept in play?
AuntMinnie
OCTOBER 31, 2023
The technology figured prominently in five Minnies categories, including Hottest Clinical Procedure. Pickhardt believes using additional clinical data on CT imaging could save healthcare costs, especially when AI tools are used in parallel, suggesting it is a cost-effective or even cost-saving strategy for personalized or precision medicine.
AuntMinnie
APRIL 4, 2024
Our goal is to investigate neurodegenerative diseases by 2026-2030, as well as other diseases that fall more under psychiatry, such as schizophrenia and bipolar disorders. More generally, correlating the states of consciousness to the connectome landscape status may also be the subject of exciting research," he noted.
AuntMinnie
FEBRUARY 23, 2024
The company also said with its completion of transactions, it has reduced its debt and extended outstanding debt maturities with new maturity dates ranging from 2028 to 2030. The company said this funding will help expand its clinical services and extend its technology and AI capabilities.
Expert insights. Personalized for you.
321 
Let's personalize your content